A recent study indicated that HOCl also alters the physi- as a potential in vivo oxidant is underlined by the presence of enzymatically-active MPO in human atheroscle-OXIDATION OF LOW-DENSITY LIPOPROTEINS rotic lesions [4] . Moreover, it has been demonstrated (LDL) ON PROTEIN MOIETY: A NOVEL that MPO is able to bind to LDL, enhancing site-directed
PATHWAY IN ATHEROGENESIS?
oxidation of the lipoprotein [5] . Most importantly, specific HOCl-dependent oxidation markers were identified Lipoprotein oxidation is involved in the genesis of in the development of atherosclerotic lesions, strongly atherosclerosis. Several methods have been developed supporting the involvement of the MPO-H 2 O 2 -chloride to promote LDL oxidation in vitro. However, it proved system. Both mass spectrometry analysis [6] and immuto be difficult to identify the mechanisms that are physionohistochemical studies [7, 8] demonstrated that HOCllogically relevant in vivo. Both the lipid and the protein generated protein oxidation products are present in moieties of LDL are subject to oxidation, and both can be human atherosclerotic lesions. The pathophysiologic reloxidized in vivo [1] . Oxidation of the LDL-lipid moiety is evance of protein oxidation products, such as plasma commonly thought to represent the initial step of oxidaadvanced oxidation protein products (AOPP), has altive LDL modification. Nevertheless, in vitro, this oxidaready been documented in the context of coronary artery tive pathway requires the presence of high concentradisease in nonuremic subjects [9] . tions of free metal ions (e.g., copper or iron), and due to multiple redundant mechanisms for chelating redoxactive free metal ions in vivo, the role of free transition PROTEIN OXIDATION PRODUCTS metal ions has been questioned. Moreover, Heinecke's AND UREMIA group cannot find evidence of metal-induced lipoprotein Oxidative stress has been implicated in the cardiovasdamage at early stages of human atherosclerotic plaque cular complications that affect chronic renal failure (CRF) formation [1] . Although lipid peroxidation could also patients [10] . We have previously shown that uremic lead to oxidative modification of apolipoprotein B100 patients, in addition to having several lipoprotein distur-(apo B100), the core protein of LDL, another pathway, bances, present protein oxidation products, such as AOPP or carbonyls [11, 12] . An increase in plasma 3-chlorotyro- 
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patients [13] . The demonstration of markedly elevated concentrations of HOCl-modified protein in the plasma of CRF patients [12] [13] [14] [15] , and the presence of oxidatively modified lipoproteins in kidney vascular structures [16] would indicate enhanced MPO activity in blood and various tissues of uremic patients, including the arterial wall.
In keeping with this, it has been shown that basal plasma MPO activity levels of patients on regular hemodialysis treatment were higher than those of healthy controls [17] . Of note, we recently found that plasma AOPP was associated with common carotid artery intima-media thickness (CCA-IMT), a process probably exacerbated by intravenous iron administration in patients undergoing epoetin therapy [18] . This observation supports the role of protein oxidation products in the early atherosclerosis of dialysis patients. Growing evidence shows that HOCl-oxLDL exert biological functions distinct of those known for copperoxLDL. Zabe et al [19] showed that HOCl-oxLDL has the potential for altering platelet function, with properengulfed without inducing an inflammatory response. ties different from those of the copper-oxidized counterHowever, this dogma was recently challenged by studies parts. Likewise, Woenckhaus et al [20] demonstrated that showing Fas-mediated activation of several pro-inflamoxLDL generated by metal ion catalysis predominantly matory genes during the apoptotic process [25] . In addirelease monocyte chemotactic factors, such as MCP-1 tion, with regard to atherosclerotic plaques, recent in (monocyte chemotactic protein-1), whereas HOCl-oxLDL vitro studies have suggested that the removal of apoinduce the secretion and synthesis of the chemokine inptotic cells may be inefficient in such a complex tissue terleukin 8 in human monocytes. Moreover, we showed [26] . Moreover, apoptosis, through its procoagulant and in our laboratory that HOCl-oxLDL were more potent proadhesive potentials, may play a critical role in both than copper-oxLDL in inducing macrophage respiratory plaque and blood thrombogenicity, and may be an imporburst and retained this activating potential even after tant step in the transition from stable to unstable atherodelipidation. This observation is in support of a crucial sclerotic disease [27] . In keeping with this, an increased role of the protein moiety of oxLDL in the macrophagenumber of MPO-expressing macrophages is detected in mediated oxidative injury involved in atherogenesis [21] . eroded or ruptured plaques, causing acute coronary synAtherosclerosis can be considered as a chronic indromes, but not in human fatty streaks, supporting a possiflammatory disease associated with enhanced apoptotic In these studies, the latter are classically produced by E-mail: vicca@necker.fr incubation with copper sulfate. In a recent study [24] , we tested the hypothesis that oxidation of LDL-protein REFERENCES moiety might induce monocyte-macrophage apoptosis, 
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